Haemonetics Corp.

NYSE:HAE   4:00:00 PM EDT
-0.04 (-0.04%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.56B
Current PE39.56
Forward PE 23.64
2yr Forward PE 21.04
See more stats
Estimates Current Quarter
Revenue$313.1 Million
Adjusted EPS$0.89
See more estimates
10-Day MA$90.25
50-Day MA$90.12
200-Day MA$84.42
See more pivots

Haemonetics Corp. Stock, NYSE:HAE

125 Summer Street, Boston, Massachusetts 02110
United States of America
Phone: +1.781.848.7100
Number of Employees: 3034


Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.